Development
Taysha Gene Therapies, Inc.
TSHA
$2.84
-$0.04-1.39%
NASDAQ
09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 264.39% | -28.92% | -27.83% | 156.17% | -48.21% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -48.05% | 12.17% | 17.50% | 4.68% | -22.02% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 1.68% | -4.39% | -0.77% | -4.33% | -16.25% |
Total Current Assets | 217.48% | -25.21% | -24.95% | 124.22% | -44.03% |
|
|||||
Total Current Assets | 217.48% | -25.21% | -24.95% | 124.22% | -44.03% |
Net Property, Plant & Equipment | -14.15% | -3.17% | -2.38% | -59.49% | 4.82% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | -25.60% | 0.00% | -12.39% | 0.58% |
Total Assets | 140.08% | -19.74% | -19.54% | 13.28% | -21.68% |
|
|||||
Total Accounts Payable | -30.15% | 19.60% | -17.76% | -28.23% | -36.37% |
Total Accrued Expenses | -34.29% | 23.22% | 0.09% | -4.22% | -10.02% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -6.11% | -6.51% | 15.19% | -- | -- |
Total Finance Division Other Current Liabilities | 664.65% | -29.43% | -18.28% | 1,021.73% | 19.73% |
Total Other Current Liabilities | 664.65% | -29.43% | -18.28% | 1,021.73% | 19.73% |
Total Current Liabilities | 256.33% | -7.00% | -13.27% | 89.47% | -22.85% |
|
|||||
Total Current Liabilities | 256.33% | -7.00% | -13.27% | 89.47% | -22.85% |
Long-Term Debt | 0.51% | 0.51% | 0.51% | 0.51% | 0.51% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -2.53% | -2.32% | 2.43% | -19.83% | -0.44% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -35.41% | 207.51% | -27.48% | 4.98% | 13.05% |
Total Liabilities | 106.38% | 1.81% | -7.00% | 24.90% | -8.47% |
|
|||||
Common Stock & APIC | 25.85% | 0.60% | 0.43% | 12.69% | 1.34% |
Retained Earnings | -26.39% | -5.87% | -4.39% | -16.04% | -8.23% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -32.33% | -148.29% | -1,675.13% | -91.47% | -65.99% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -32.33% | -148.29% | -1,675.13% | -91.47% | -65.99% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -32.33% | -148.29% | -1,675.13% | -91.47% | -65.99% |
|